Evidence map›Paper›PMID 26242374›Full record

ArticleRadiation and environmental biophysics2015

Enhanced production of reactive oxygen species by gadolinium oxide nanoparticles under core-inner-shell excitation by proton or monochromatic X-ray irradiation: implication of the contribution from the interatomic de-excitation-mediated nanoradiator effect to dose enhancement.

Seung-Jun Seo, Sung-Mi Han, Jae-Hoon Cho, Kazuyuki Hyodo, Alexander Zaboronok, He You, Ken Peach, Mark A Hill, Jong-Ki Kim

Abstract read
PubMed Publisher
In one paragraph

Article in Radiation and environmental biophysics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Metal-basedTheranostics · 2018
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Seung-Jun SeoBiomedical Engineering and Radiology, School of Medicine, Catholic University of Daegu, Daegu, Korea.
Sung-Mi HanAnatomy, School of Medicine, Catholic University of Daegu, Daegu, Korea.
Jae-Hoon ChoNeurosurgery, School of Medicine, Catholic University of Daegu, Daegu, Korea.
Kazuyuki HyodoHigh Energy Accelerator Research Organization (KEK), Photon Factory, Tsukuba, Japan.
Alexander ZaboronokDepartment of Neurosurgery, University of Tsukuba, Tsukuba, Ibaraki, Japan.
He YouShanghai Synchrotron Radiation Facility, Shanghai, China.
Ken PeachParticle Therapy Cancer Research Institute, University of Oxford, Oxford, UK.
Mark A HillGray Institute for Radiation Oncology and Biology, University of Oxford, Oxford, UK.
Jong-Ki KimBiomedical Engineering and Radiology, School of Medicine, Catholic University of Daegu, Daegu, Korea. jkkim@cu.ac.kr.
Catholic University of Daegu · KRCancer Research UK Oxford Centre · GBCRUK/MRC Oxford Institute for Radiation Oncology · GBHigh Energy Accelerator Research Organization · JPShanghai Synchrotron Radiation FacilityUniversity of Tsukuba · JP

Funding

Medical Research Council MC_U142760473
6 · The paper itself

Abstract

Core-inner-valence ionization of high-Z nanoparticle atomic clusters can de-excite electrons through various interatomic de-excitation processes, thereby leading to the ionization of both directly exposed atoms and adjacent neutral atoms within the nanoparticles, and to an enhancement in photon-electron emission, which is termed the nanoradiator effect. To investigate the nanoradiator-mediated dose enhancement in the radio-sensitizing of high-Z nanoparticles, the production of reactive oxygen species (ROS) was measured in a gadolinium oxide nanoparticle (Gd-oxide NP) solution under core-inner-valence excitation of Gd with either 50 keV monochromatic synchrotron X-rays or 45 MeV protons. This measurement was compared with either a radiation-only control or a gadolinium-chelate magnetic resonance imaging contrast agent solution containing equal amounts of gadolinium as the separate atomic species in which Gd-Gd interatomic de-excitations are absent. Ionization excitations followed by ROS measurements were performed on nanoparticle-loaded cells or aqueous solutions. Both photoexcitation and proton impact produced a dose-dependent enhancement in the production of ROS by a range of factors from 1.6 to 1.94 compared with the radiation-only control. Enhanced production of ROS, by a factor of 1.83, was observed from Gd-oxide NP atomic clusters compared with the Gd-chelate molecule, with a Gd concentration of 48 μg/mL in the core-level photon excitation, or by a factor of 1.82 under a Gd concentration of 12 μg/mL for the proton impact at 10 Gy (p < 0.02). The enhanced production of ROS in the irradiated nanoparticles suggests the potential for additional therapeutic dose enhancements in radiation treatment via the potent Gd-Gd interatomic de-excitation-driven nanoradiator effect.

Indexed as

Contrast MediaDose-Response Relationship, RadiationGadoliniumLinear Energy TransferMaterials TestingMetal NanoparticlesProtonsRadiation DosageReactive Oxygen SpeciesScattering, RadiationX-RaysContrast MediaGadoliniumgadolinium oxideProtonsReactive Oxygen SpeciesInner-shell ionizationInteratomic de-excitationLow-energy electronsNanoparticle atomic clustersNanoradiator effectRadiosensitizationReactive oxygen species

Identifiers

PMID26242374
OpenAlexW1072606498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.